Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mudassier Ahmad
Observed name:
Ahmad, Mudassier
Institution:
The University of Texas Rio Grande Valley
Observed institutions:
The University of Texas Rio Grande Valley,
Indian Institute of Integrative Medicine,
Fred and Pamela Buffett Cancer Center,
University of Nebraska Medical Center,
Council of Scientific and Industrial Research
ORCID:
0000-0002-8953-4759
Observed ORCID:
0000-0002-8953-4759
OpenAlex ID:
A5033575819
Ring A structural modified derivatives of withaferin A and the evaluation of their cytotoxic potential
2011
·
Syed Khalid Yousuf
, Rabiya Majeed
, et al.
·
Steroids
·
63
Recent Development in Targeting PI3K-Akt-mTOR Signaling for Anticancer Therapeutic Strategies
2013
·
Asif Qazi
, Aashiq Hussain
, et al.
·
Anti-Cancer Agents in Medicinal Chemistry
·
31
Understanding Histone Deacetylases in the Cancer Development and Treatment: An Epigenetic Perspective of Cancer Chemotherapy
2012
·
Mudassier Ahmad
, Abid Hamid
, et al.
·
DNA and Cell Biology
·
28
Exploring Derivatives of Quinazoline Alkaloid l -Vasicine as Cap Groups in the Design and Biological Mechanistic Evaluation of Novel Antitumor Histone Deacetylase Inhibitors
2017
·
Mudassier Ahmad
, Mushtaq A. Aga
, et al.
·
Journal of Medicinal Chemistry
·
23
Design, synthesis and biological evaluation of β-boswellic acid based HDAC inhibitors as inducers of cancer cell death
2014
·
Simmi Sharma
, Mudassier Ahmad
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
21
Honey Targets Ribosome Biogenesis Components to Suppress the Growth of Human Pancreatic Cancer Cells
2024
·
Aun Ali Bangash
, Sahir Sultan Alvi
, et al.
·
Cancers
·
12
Mitochondrial ribosomal protein L3 (MRPL3): An early diagnostic biomarker and potential molecular target in pancreatic cancer
2025
·
Mudassier Ahmad
, Sahir Sultan Alvi
, et al.
·
Translational Oncology
·
10
Spirocyclic dimer SpiD7 activates the unfolded protein response to selectively inhibit growth and induce apoptosis of cancer cells
2022
·
Smit Kour
, Sandeep Rana
, et al.
·
Journal of Biological Chemistry
·
10
PDF
Chemokine clouding and liver cancer heterogeneity: Does it impact clinical outcomes?
2022
·
Mudassier Ahmad
, Anupam Dhasmana
, et al.
·
Seminars in Cancer Biology
·
6
PDF
Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth
2025
·
Mudassier Ahmad
, Sahir Sultan Alvi
, et al.
·
Molecular Cancer Therapeutics
·
4
Abstract B035: Targeting ribosome biogenesis addition is a novel strategy for pancreatic cancer therapy
2022
·
Mudassier Ahmad
, Carlos Perez
, et al.
·
Cancer Research
·
1
Abstract 3950: Targeting ribosome biogenesis is a novel strategy to suppress the growth of pancreatic cancer
2022
·
Carlos Perez
, Mudassier Ahmad
, et al.
·
Cancer Research
·
1
Abstract 1376: Novel HDAC inhibitor SBAK-GHA: potential therapuetic molecule for lymophocytic leukaemia
2017
·
Javeed Ahmad Bhat
, Mudassier Ahmad
, et al.
·
Cancer Research
·
1
Supplementary Figure 8 from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth
2026
·
Mudassier Ahmad
, Sahir Sultan Alvi
, et al.
Supplementary Figure 7 from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth
2026
·
Mudassier Ahmad
, Sahir Sultan Alvi
, et al.
Supplementary Tables from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth
2026
·
Mudassier Ahmad
, Sahir Sultan Alvi
, et al.
Data from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth
2026
·
Mudassier Ahmad
, Sahir Sultan Alvi
, et al.
Supplementary Figure 6 from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth
2026
·
Mudassier Ahmad
, Sahir Sultan Alvi
, et al.
Supplementary Figure 5 from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth
2026
·
Mudassier Ahmad
, Sahir Sultan Alvi
, et al.
Supplementary Figure 9 from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth
2026
·
Mudassier Ahmad
, Sahir Sultan Alvi
, et al.
Supplementary Figure 3 from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth
2026
·
Mudassier Ahmad
, Sahir Sultan Alvi
, et al.
Supplementary Figure 4 from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth
2026
·
Mudassier Ahmad
, Sahir Sultan Alvi
, et al.
Supplementary Data 1 from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth
2026
·
Mudassier Ahmad
, Sahir Sultan Alvi
, et al.
Supplementary Figure 1 from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth
2026
·
Mudassier Ahmad
, Sahir Sultan Alvi
, et al.
Supplementary Figure 2 from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth
2026
·
Mudassier Ahmad
, Sahir Sultan Alvi
, et al.
Show more works
View as search
Works count:
39
Citation count:
211
H-index:
8
I10-index:
8
Year
Topic
Type